Predictors of Vitamin D Status in Predialysis Chronic Kidney Disease Patients: A Cross-sectional Analysis in a High Ultraviolet Climate

2009 Petchey, 2011, Shining D’ light on CKD: mechanisms that may underpin the cardiovascular benefit of vitamin d in chronic kidney disease, Nephrology (Carlton), 16, 351, 10.1111/j.1440-1797.2011.01450.x Holick, 2007, Vitamin D deficiency, N Engl J Med, 357, 266, 10.1056/NEJMra070553 Cuppari, 2008, Vitamin D status of chronic kidney disease patients living in a sunny country, J Ren Nutr, 18, 408, 10.1053/j.jrn.2008.05.004 Levey, 2006, Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate, Ann Intern Med, 145, 247, 10.7326/0003-4819-145-4-200608150-00004 2002, K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am J Kidney Dis, 39, S1 Johnson DW. Diagnosis, classification and staging of chronic kidney disease. Caring for Australasians with renal impairment (CARI) guidelines [draft], 2011. Available at: http://www.cari.org.au/DNT workshop 2011/5 Classification Staging_Early CKD_DNT.pdf. Accessed May 12, 2011. 2003, K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease, Am J Kidney Dis, 42, S1 Levin, 2007, Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease, Kidney Int, 71, 31, 10.1038/sj.ki.5002009 LaClair, 2005, Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States, Am J Kidney Dis, 45, 1026, 10.1053/j.ajkd.2005.02.029 McGrath, 2001, Vitamin D insufficiency in south-east Queensland, Med J Aust, 174, 150, 10.5694/j.1326-5377.2001.tb143195.x Kimlin, 2007, Does a high UV environment ensure adequate vitamin D status?, J Photochem Photobiol B, 89, 139, 10.1016/j.jphotobiol.2007.09.008 Matsuoka, 1990, Use of topical sunscreen for the evaluation of regional synthesis of vitamin D3, J Am Acad Dermatol, 22, 772, 10.1016/0190-9622(90)70107-S Scragg, 2004, Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third national health and nutrition examination survey, Diabetes Care, 27, 2813, 10.2337/diacare.27.12.2813 Figuiredo-Dias V, Cuppari L, Garcia-Lopes MG, de Carvalho AB, Draibe SA, Kamimura MA. Risk factors for hypovitaminosis d in nondialyzed chronic kidney disease patients. J Ren Nutr. In press. Thomas, 1998, Hypovitaminosis D in medical inpatients, N Engl J Med, 338, 777, 10.1056/NEJM199803193381201 DeVille, 2006, Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease, Nephrology (Carlton), 11, 555, 10.1111/j.1440-1797.2006.00698.x Al Aly, 2007, Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD, Am J Kidney Dis, 50, 59, 10.1053/j.ajkd.2007.04.010 Zisman, 2007, Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease, Am J Nephrol, 27, 36, 10.1159/000098561 Chandra, 2008, Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study, Endocr Pract, 14, 10, 10.4158/EP.14.1.10 Clayton, 2009, 25-Hydroxyvitamin D levels in prevalent Australian dialysis patients, Nephrology (Carlton), 14, 554, 10.1111/j.1440-1797.2009.01145.x